GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immuno-Biological Laboratories Co Ltd (TSE:4570) » Definitions » Market Cap

Immuno-Biological Laboratories Co (TSE:4570) Market Cap : 円4,470.5 Mil (As of Apr. 01, 2025)


View and export this data going back to 2007. Start your Free Trial

What is Immuno-Biological Laboratories Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Immuno-Biological Laboratories Co's share price for the quarter that ended in Sep. 2024 was 円428. Immuno-Biological Laboratories Co's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 9.3 Mil. Therefore, Immuno-Biological Laboratories Co's market cap for the quarter that ended in Sep. 2024 was 円3,986.0 Mil.

Immuno-Biological Laboratories Co's quarterly market cap increased from Dec. 2023 (円4,591.3 Mil) to Mar. 2024 (円4,935.9 Mil) but then declined from Mar. 2024 (円4,935.9 Mil) to Sep. 2024 (円3,986.0 Mil).

Immuno-Biological Laboratories Co's annual market cap increased from Mar. 2022 (円3,045.4 Mil) to Mar. 2023 (円3,790.4 Mil) and increased from Mar. 2023 (円3,790.4 Mil) to Mar. 2024 (円4,935.9 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Immuno-Biological Laboratories Co's Enterprise Value for Today is 円3,936.8 Mil.


Immuno-Biological Laboratories Co Market Cap Historical Data

The historical data trend for Immuno-Biological Laboratories Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immuno-Biological Laboratories Co Market Cap Chart

Immuno-Biological Laboratories Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,001.08 5,140.78 3,045.35 3,790.39 4,935.89

Immuno-Biological Laboratories Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,417.87 5,261.85 4,591.31 4,935.89 3,985.96

Competitive Comparison of Immuno-Biological Laboratories Co's Market Cap

For the Biotechnology subindustry, Immuno-Biological Laboratories Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immuno-Biological Laboratories Co's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immuno-Biological Laboratories Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Immuno-Biological Laboratories Co's Market Cap falls into.


;
;

Immuno-Biological Laboratories Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Immuno-Biological Laboratories Co's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )=Share Price (A: Mar. 2024 )*Shares Outstanding (EOP) (A: Mar. 2024 )
=円530*9.313
=円4,935.9

Immuno-Biological Laboratories Co's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=円428*9.313
=円3,986.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Immuno-Biological Laboratories Co  (TSE:4570) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Immuno-Biological Laboratories Co Market Cap Related Terms

Thank you for viewing the detailed overview of Immuno-Biological Laboratories Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Immuno-Biological Laboratories Co Business Description

Traded in Other Exchanges
N/A
Address
1091-1 Naka Aza-Higashida, Gunma, Fujioka, JPN, 375-0005
Immuno-Biological Laboratories Co Ltd focuses on research and development. It researches, develops, manufacture and supplies various immunological research reagents, and customized services. It is engaged in research and development of materials used in diagnostic products and valuable seeds and technology for protein production using transgenic silkworm cocoons, which make it possible to create valuable proteins as well as antibodies. It works on clinical reagents for cancer research. Its research scientists are producing inflammatory cytokines, growth factors & antibodies for use against these cancers.

Immuno-Biological Laboratories Co Headlines

No Headlines